SEC Form D filing
Biologic Capital, Inc.
Biotech · Regulation D 506(b) · CA · Filed May 13, 2026
Offering amount
Undisclosed
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
May 13, 2026
Signature date
—
CIK
0002134754
Summary
Biologic Capital name suggests biotech focus; no offering amount disclosed.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.